American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 3(65), 2021
DOI: 10.1128/aac.02422-20
Full text: Download
Human cytomegalovirus (HCMV) is a ubiquitous pathogen that can cause developmental disorders following congenital infection and life-threatening complications among transplant patients. Potent neutralizing monoclonal antibodies (MAbs) are promising drug candidates against HCMV infection.